EARNINGS AND TRADING: ZCCM names Joackim Bantubonse as new CFO
The following is a round-up of earnings reports and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
----------
Town Centre Securities PLC - Leeds, England-based property investor, car park and hotel operator - Proposes final dividend of 2.5 pence for the year ended June 30, keeping the total unchanged year-on-year at 5.0p. Net assets decrease to 258p per share as of June 30, from 266p one year prior. EPRA net tangible assets decrease to 255p from 261p. Gross revenue increases 4.6% to £34.2 million from £32.7 million the year before. Net revenue rises 6.9% to £15.9 million from £14.9 million. Pretax loss narrows to £345,000 from £1.1 million. Town Centre Securities says resilient trading has continued into the first half of the current financial year, with "robust" rent collections and trading in line with guidance from its car park and hotel businesses. "This has been another year of stability for Town Centre Securities," says Chair & Chief Executive Edward Ziff. "The business delivered sound results for the year, despite the volatile macroeconomic backdrop."
----------
Newmark Security PLC - London-based security and workforce management company - Reports group revenue of £26.4 million for the year ended April 30, up 15% from £23.0 million the previous year. Human Capital Management revenue rises 27% £19.5 million from £15.4 million, with HCM North American revenue jumping 43% to £14.1 million from £9.9 million. Revenue rises to £21.9 million from £18.1 million. Pretax profit rises to £1.9 million from £1.5 million. Continuing earnings before interest, tax, depreciation and amortisation rise 19% to £3.5 million from £2.9 million. Chair Maurice Dwek says Newmark "entered FY27 with a clear strategic focus on HCM as the Group's principal operating business," noting that in the latest year, "HCM added new tier-1 partners, grew subscription revenues, recorded the first D2E revenues, and expanded its sales pipeline." Dwek also says: "FY26 has been a year of key decisions as well as record revenues...The opportunity ahead for HCM is genuinely exciting, and I am confident the team has everything required to seize it."
----------
Fandango Holdings PLC - London-based investment company focused on the industrial and services sectors - Reports final results for the year ended February 28. Pretax loss widens to £184,000 from £62,000. 'Other income' decreases to £56,000 from £394,000, but administrative expenses & listing costs fall to £239,000 from £455,000.
----------
ZCCM Investment Holdings PLC - Zambia-focused mining investment company - Appoints Joackim Bantubonse as chief financial officer, with effect from Wednesday, October 14. Bantubonse was previously regional finance director at Gemfields Ltd, "overseeing operations in Mozambique and Mauritius, where he provided financial leadership and secured funding to support business growth." Company says he is "an experienced finance executive with extensive expertise in financial management, strategic planning, treasury management, capital raising, mining operations and corporate governance." It is "confident that his extensive experience in the financial and mining sectors will strengthen the company's financial management and support the achievement of its strategic objectives."
----------
Syncona Ltd - London-based life science investor - Invests in USD310 million Series C financing round by portfolio company OMass Therapeutics, which is developing small molecule therapeutics to treat rare diseases and immunological conditions. Syncona has committed USD10.1 million. All other existing investors also participated in the funding round. OMass has now raised approximately USD475 million in total. Series C proceeds will support the advancement of OMass' lead programme, OMS1620, a potential treatment of congenital adrenal hyperplasia and ACTH-dependent Cushing's syndrome. It will also support the firm's earlier-stage pipeline, which includes the generation of initial clinical data for its next candidate.
----------
Copyright 2026 Alliance News Ltd. All Rights Reserved.